Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, signaling a new build or update. This reflects an internal platform or documentation update rather than a change to the study details displayed on the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check39 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded a related topic for Marinesco-Sjögren syndrome. Included a resources section linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The update appears to concern site versioning rather than the study details.SummaryDifference0.0%

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.